{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:28:43Z","timestamp":1789453723705,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurot.2024.e00514","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:26:55Z","timestamp":1734539215000},"page":"e00514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Strategies to innovate emergency care of status epilepticus"],"prefix":"10.1016","volume":"22","author":[{"given":"Jaideep","family":"Kapur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neurot.2024.e00514_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A\u00a0definition and classification of status epilepticus - report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00514_bib2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1528-1167.2006.00622.x","article-title":"How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit","volume":"47","author":"Jenssen","year":"2006","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00514_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.1018","article-title":"How long do new-onset seizures in children last?","volume":"49","author":"Shinnar","year":"2001","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00514_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.0b013e318266fcc5","article-title":"MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study","volume":"79","author":"Shinnar","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2024.e00514_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17979","article-title":"Hippocampal sclerosis and temporal lobe epilepsy following febrile status epilepticus: the FEBSTAT study","author":"Lewis","year":"2024","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.24081","article-title":"Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study","volume":"75","author":"Lewis","year":"2014","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.neurot.2024.e00514_bib7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1212\/WNL.0b013e3182759766","article-title":"Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study","volume":"79","author":"Nordli","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00514_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Pitk\u00e4nen","year":"2011","journal-title":"Lancet Neurol"},{"issue":"9531","key":"10.1016\/j.neurot.2024.e00514_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2024.e00514_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1528-1157.1992.tb06223.x","article-title":"Status epilepticus in children, adults, and the elderly","volume":"33","author":"DeLorenzo","year":"1992","journal-title":"Epilepsia"},{"issue":"18","key":"10.1016\/j.neurot.2024.e00514_bib12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00514_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archneurol.2010.169","article-title":"Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review","volume":"67","author":"Neligan","year":"2010","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WNP.0000000000000166","article-title":"Consensus statement on continuous EEG in critically Ill adults and children, part I: indications","volume":"32","author":"Herman","year":"2015","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00514_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection\u2013related epilepsy syndrome (FIRES): state of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00514_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurot.2024.e00514_bib17","author":"Shorvon"},{"issue":"22","key":"10.1016\/j.neurot.2024.e00514_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00514_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"A\u00a0progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00514_bib20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1528-1167.2008.01911.x","article-title":"EEG stages predict treatment response in experimental status epilepticus","volume":"50","author":"Wang","year":"2009","journal-title":"Epilepsia"},{"issue":"10231","key":"10.1016\/j.neurot.2024.e00514_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.neurot.2024.e00514_bib22","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+sensitivity of hippocampal dentate granule cell GABA(A) receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00514_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(25)09292-2","article-title":"Pharmacological properties of \u03b3-aminobutyric acid(A) receptors from acutely dissociated rat dentate granule cells","volume":"50","author":"Kapur","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00514_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABA(A) receptor channels","volume":"17","author":"Macdonald","year":"1994","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABA(A) receptor diversity and pharmacology","volume":"326","author":"H M","year":"2006","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.brainres.2004.09.056","article-title":"Distribution of \u03b11, \u03b14, \u03b32, and \u03b4 subunits of GABA A receptors in hippocampal granule cells","volume":"1029","author":"Sun","year":"2004","journal-title":"Brain Res"},{"issue":"24","key":"10.1016\/j.neurot.2024.e00514_bib27","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by \u03b4 subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00514_bib28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0896-6273(95)90274-0","article-title":"Tonic inhibition originates from synapses close to the soma","volume":"14","author":"Soltesz","year":"1995","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00514_bib29","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABAA receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J\u00a0Neurosci"},{"issue":"23","key":"10.1016\/j.neurot.2024.e00514_bib30","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABA A receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00514_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ana.410380609","article-title":"Experimental status epilepticus alters \u03b3-aminobutyric acid type A receptor function in CA1 pyramidal neurons","volume":"38","author":"Kapur","year":"1995","journal-title":"Ann Neurol"},{"issue":"51","key":"10.1016\/j.neurot.2024.e00514_bib32","doi-asserted-by":"crossref","first-page":"14012","DOI":"10.1523\/JNEUROSCI.4390-07.2007","article-title":"Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy","volume":"27","author":"Pathak","year":"2007","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00514_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40263-023-01060-1","article-title":"Benzodiazepines for the treatment of seizure clusters","volume":"38","author":"Penovich","year":"2024","journal-title":"CNS Drugs"},{"issue":"26","key":"10.1016\/j.neurot.2024.e00514_bib34","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","article-title":"A\u00a0comparison of rectal diazepam gel and placebo for acute repetitive seizures","volume":"338","author":"Dreifuss","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00514_bib35","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/epi.15159","article-title":"Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Detyniecki","year":"2019","journal-title":"Epilepsia"},{"issue":"16","key":"10.1016\/j.neurot.2024.e00514_bib36","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial","volume":"311","author":"Chamberlain","year":"2014","journal-title":"JAMA, J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00514_bib37","doi-asserted-by":"crossref","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Current"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00514_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00514_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A\u00a0comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00514_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A\u00a0comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 8","key":"10.1016\/j.neurot.2024.e00514_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","article-title":"RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics","volume":"52","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"issue":"19","key":"10.1016\/j.neurot.2024.e00514_bib42","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1001\/jama.2021.15964","article-title":"Prehospital treatment of status epilepticus in the United States","volume":"326","author":"Guterman","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00514_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurot.2024.e00514_bib44","series-title":"Underdosing of benzodiazepines in patients with status epilepticus enrolled in established status epilepticus treatment trial","author":"Sathe","year":"2019"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00514_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12028-014-0106-5","article-title":"Endotracheal intubation in patients treated for prehospital status epilepticus","volume":"23","author":"Neurological Emergencies Treatment Trials (NETT) Investigators","year":"2015","journal-title":"Neurocrit Care"},{"issue":"suppl 6","key":"10.1016\/j.neurot.2024.e00514_bib46","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurot.2024.e00514_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.04.049","article-title":"Lessons from the established status epilepticus treatment trial","volume":"101","author":"Cock","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"10186","key":"10.1016\/j.neurot.2024.e00514_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"10186","key":"10.1016\/j.neurot.2024.e00514_bib49","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2024.e00514_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.109066","article-title":"Why ketamine","volume":"141","author":"Coles","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"S2","key":"10.1016\/j.neurot.2024.e00514_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/epi4.12270","article-title":"Role of NMDA receptors in the pathophysiology and treatment of status epilepticus","volume":"3","author":"Kapur","year":"2018","journal-title":"Epilepsia Open"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:25:45Z","timestamp":1740122745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1878747924002010"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00514","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to innovate emergency care of status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00514"}}